Filtros de búsqueda

Lista de obras de Kenji Nakano

Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients

artículo científico publicado en 2020

Corrigendum: Genome-wide analysis of mammalian promoter architecture and evolution

scholarly article published in Nature Genetics

Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.

artículo científico publicado en 2018

Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.

artículo científico publicado en 2012

Genome-wide analysis of mammalian promoter architecture and evolution

artículo científico publicado en 2006

Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab

scientific article published on 04 March 2019

Incidence of Pneumothorax in Advanced and/or Metastatic Soft Tissue Sarcoma Patients during Pazopanib Treatment

scientific article published on 12 March 2014

Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis

artículo científico publicado en 2020

Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy

artículo científico publicado en 2015

Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders

scientific article published on 08 January 2019

The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.

artículo científico publicado en 2015

The VAC regimen for adult rhabdomyosarcoma: Differences between adolescent/young adult and older patients

scientific article published on 28 October 2019

Translocation-Related Sarcomas

scientific article published in 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda